Drugs / Grazoprevir/Elbasvir
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02647632 | Jan 2016 → Jan 2017 | hepatitis C virus infection | ANRS, Emerging Infectious Diseases | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Grazoprevir/Elbasvir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02647632 ↗ |